UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

Annals of oncology, 2010-07, Vol.21 (7), p.1492-1499

2010

Volltextzugriff (PDF)

P-180Health-related quality of life in patients with metastatic pancreatic cancer

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii53-ii53

2016

Volltextzugriff (PDF)

Budget Impact of Albumin-Bound Paclitaxel + Gemcitabine in the Treatment of Metastatic Pancreatic Cancer

Value in health, 2014-05, Vol.17 (3), p.A74-A74

2014

Volltextzugriff (PDF)

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

British journal of cancer, 2001-09, Vol.85 (5), p.649-655

2001

Volltextzugriff (PDF)

Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin

British journal of cancer, 2005-05, Vol.92 (9), p.1684-1689

2005

Volltextzugriff (PDF)

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1600-1608

1995

Volltextzugriff (PDF)

A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer

Annals of oncology, 1998-12, Vol.9 (12), p.1343-1345

1998

Volltextzugriff (PDF)

P-174 The role of gastroenterologists in providing initial information on treatment options for patients with pancreatic cancer (PC) in the United States and Europe: a global quantitative survey

Annals of oncology, 2015-06, Vol.26, p.iv50

2015

Volltextzugriff (PDF)

Phase I–II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma

Annals of oncology, 2002-09, Vol.13 (9), p.1479-1489

2002

Volltextzugriff (PDF)

165TiP A first-in-human phase I study of FS222, a CD137/PD-L1 tetravalent bispecific antibody, in patients with advanced malignancies

Annals of oncology, 2021-12, Vol.32, p.S1454

2021

Volltextzugriff (PDF)

Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients

Annals of oncology, 2003-09, Vol.14 (9), p.1383-1390

2003

Volltextzugriff (PDF)

1033TiP A first-in-human phase I study of FS120, an OX40/CD137 tetravalent bispecific antibody, in patients with advanced malignancies

Annals of oncology, 2021-09, Vol.32, p.S864-S865

2021

Volltextzugriff (PDF)

P-180 Health-related quality of life in patients with metastatic pancreatic cancer

Annals of oncology, 2016-06, Vol.27, p.ii53

2016

Volltextzugriff (PDF)

Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

Annals of oncology, 2003-08, Vol.14 (8), p.1246-1252

2003

Volltextzugriff (PDF)

P-186 International phase II trial of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients with locally advanced pancreatic cancer (LAPC): LAPACT

Annals of oncology, 2015-06, Vol.26, p.iv54

2015

Volltextzugriff (PDF)

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Clinical cancer research, 2005-01, Vol.11 (2), p.690-696

2005

Volltextzugriff (PDF)

Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study

Gynecologic oncology, 2003-10, Vol.91 (1), p.32-38

2003

Volltextzugriff (PDF)

173P First-in-human study to evaluate the safety and clinical activity of FS222: A tetravalent bispecific antibody targeting PD-L1 and CD137, in patients with advanced solid tumors

Immuno-oncology technology, 2022-12, Vol.16, p.100285, Article 100285

2022

Volltextzugriff (PDF)

Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: A multicenter phase II study

Lung cancer (Amsterdam, Netherlands), 2006-03, Vol.51 (3), p.347-355

2006

Volltextzugriff (PDF)

PCN40 - Budget Impact of Albumin-Bound Paclitaxel + Gemcitabine in the Treatment of Metastatic Pancreatic Cancer

Value in health, 2014-05, Vol.17 (3), p.A74-A74

2014

Volltextzugriff (PDF)

Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study

Hepato-gastroenterology, 2000-09, Vol.47 (35), p.1450

2000

Volltextzugriff (PDF)

A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies

Annals of oncology, 2000-01, Vol.11 (1), p.73-79

2000

Volltextzugriff (PDF)

P3-14-13: A Prospective Open-Label Randomized Phase II Neoadjuvant Study of Non-Pegylated Liposomal Doxorubicin (MYOCET®) Plus Cyclophosphamide and Trastuzumab Versus Conventional Doxorubicin Plus Cyclophosphamide Alone, Each Followed by Docetaxel and Trastuzumab, in HER2−Positive Breast Cancer Patients

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-14-13

2011

Volltextzugriff (PDF)

Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer

Oncology, 2001-01, Vol.60 (4), p.303-307

2001

Volltextzugriff (PDF)

Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety

Seminars in oncology, 1996-02, Vol.23 (1 Suppl 1), p.24

1996

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(50)

Sprache

Englisch
(45)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Aged
(18)
Female
(18)
Life Sciences & Biomedicine
(18)
Middle Aged
(18)
Science & Technology
(18)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Oncology
(16)
Adult
(15)
Antineoplastic Agents
(13)
Pharmacology. Drug Treatments
(13)
Chemotherapy
(12)
Deoxycytidine - Analogs & Derivatives
(9)
Male
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Gemcitabine
(7)
Treatment Outcome
(7)
Deoxycytidine - Administration & Dosage
(6)
Drug Administration Schedule
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

P-180Health-related quality of life in patients with metastatic pancreatic cancer

Budget Impact of Albumin-Bound Paclitaxel + Gemcitabine in the Treatment of Metastatic Pancreatic Cancer

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatin

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas

A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer

P-174 The role of gastroenterologists in providing initial information on treatment options for patients with pancreatic cancer (PC) in the United States and Europe: a global quantitative survey

Phase I–II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma

165TiP A first-in-human phase I study of FS222, a CD137/PD-L1 tetravalent bispecific antibody, in patients with advanced malignancies

Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients

1033TiP A first-in-human phase I study of FS120, an OX40/CD137 tetravalent bispecific antibody, in patients with advanced malignancies

P-180 Health-related quality of life in patients with metastatic pancreatic cancer

Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

P-186 International phase II trial of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients with locally advanced pancreatic cancer (LAPC): LAPACT

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study

173P First-in-human study to evaluate the safety and clinical activity of FS222: A tetravalent bispecific antibody targeting PD-L1 and CD137, in patients with advanced solid tumors

Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: A multicenter phase II study

PCN40 - Budget Impact of Albumin-Bound Paclitaxel + Gemcitabine in the Treatment of Metastatic Pancreatic Cancer

Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study

A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies

Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer

Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety

Suchergebnisse filtern